Hypersensitivity pneumonitis mortality: a global trend, a cause not found

The study published on October 26 in Scientific Reports starts from a simple baseline figure: the standardized mortality rate for hypersensitivity pneumonitis, in the 32 countries examined, grew on average by 5.43% per year between 1999 and 2019. Hypersensitivity pneumonitis is a rare lung disease linked to repeated immune reactions to inhaled substances; in the document it is identified through code J67 of the International Classification of Diseases (ICD-10), applied to deaths recorded in the World Health Organization’s mortality database.

The sample concerns people aged at least 20, followed over a span of twenty years in 32 countries whose data are available in the WHO database. It is an observational study on aggregated historical mortality series, not on individual clinical cases: it measures a trend, it does not establish its specific causes. This is demonstrated by the very result the authors attribute to a single known factor: among adults aged at least 40, population aging would explain 12.2% of the observed increase. The remaining share of the increase is therefore left unattributed, and the material available does not report other tested variables nor any conflicts of interest declared by the authors.

In the Italian press the news currently comes from a single source (Diario del Web); no independent confirmation is available from other outlets for the published rewrite. The report picks up the most immediate figure — the average annual growth of 5.43% — but in the passage from the research to the article precisely the point the study itself highlights is lost: the share of the increase that population aging does not explain. An isolated growth rate, without the limit the author himself states, risks suggesting a more defined trend than the data allow one to claim.

This matters because hypersensitivity pneumonitis is a condition that can remain under clinical observation for years before diagnosis, and a signal of rising mortality over a multi-decade, multinational scale is the type of data that health agencies use to decide where to direct epidemiological surveillance and diagnostic resources. It does not indicate, however, on its own, which environmental or occupational exposures may be weighing more heavily: the study records the trend of coded deaths, not the causes producing them, and the available material does not allow going beyond this boundary.